Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-center registry

International Journal of Cardiology

Volumn 151, Issue 1, 2011, Pages 89-95

  Park, Kyung Woo ^a   Kang, Si Hyuck ^a   Park, Keun Ho ^a   Choi, Dong Hyun ^a   Lee, Hae Young ^a   Kang, Hyun Jae ^a   Cho, Young Seok ^b   Yeon, Tae Jin ^b   Chung, Woo Young ^c   Koo, Bon Kwon ^a   Chae, In Ho ^b   Choi, Dong Ju ^b   Oh, Byung Hee ^a   Park, Young Bae ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Paclitaxel eluting stent; Percutaneous coronary intervention; Sirolimus eluting stent; Unprotected left main coronary artery stenosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; REVASCULARIZATION; RISK ASSESSMENT; STENT THROMBOSIS; UNIVERSITY HOSPITAL; UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY STENOSIS; CORONARY THROMBOSIS; DEATH, SUDDEN, CARDIAC; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SIROLIMUS;

EID: 79961162503     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.05.001     Document Type: Article

References (25)

1. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008 (Pubitemid 46376800)
2. K.B. Seung, D.-W. Park, and Y.-H. Kim Stents versus coronary-artery bypass grafting for left main coronary artery disease N Engl J Med 358 2008 1781 1792 (Pubitemid 351581190)
3. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
4. M. Valgimigli, C.A. van Mieghem, and A.T. Ong Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting and taxus stent evaluated at rotterdam cardiology hospital registries (research and t-search) Circulation 111 2005 1383 1389 (Pubitemid 40396804)
5. A. Chieffo, N. Morici, and F. Maisano Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience Circulation 113 2006 2542 2547 (Pubitemid 43948033)
6. E. Meliga, H.M. Garcia-Garcia, and M. Valgimigli Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the delft (drug eluting stent for left main) registry J Am Coll Cardiol 51 2008 2212 2219 (Pubitemid 351754998)
7. M. Valgimigli, P. Malagutti, and J. Aoki Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined research and t-search long-term analysis J Am Coll Cardiol 47 2006 507 514 (Pubitemid 43170837)
8. B.R. Chaitman, K. Davis, and L.D. Fisher A life table and cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: non-left main equivalent lesions (cass) Circulation 68 1983 1163 1170 (Pubitemid 14207027)
9. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
10. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
11. A. Kastrati, J. Mehilli, and N. von Beckerath Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171 (Pubitemid 40095867)
12. M.C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the reality trial: a randomized controlled trial JAMA 295 2006 895 904
13. A.M. Galloe, L. Thuesen, and H. Kelbaek Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the sort out II randomized trial JAMA 299 2008 409 416 (Pubitemid 351185949)
14. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
15. A. Schömig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380 (Pubitemid 47449734)
16. S.-H. Kang, K.-H. Park, and D.-J. Choi Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry) Am J Cardiol 105 2010 343 351
17. J. Mehilli, A. Kastrati, and R.A. Byrne Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease J Am Coll Cardiol 53 2009 1760 1768
18. E. Meliga, H.M. Garcia-Garcia, and M. Valgimigli Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (sp-delft) Int J Cardiol 137 2009 16 21
19. J.Y. Lee, D.W. Park, and S.C. Yun Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the main-compare (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry J Am Coll Cardiol 54 2009 853 859
20. M. Togni, S. Eber, and J. Widmer Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the sirtax trial J Am Coll Cardiol 50 2007 1123 1131 (Pubitemid 47375014)
21. A. Chieffo, S.-J. Park, and E. Meliga Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry Eur Heart J 29 2008 2108 2115
22. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
23. D.-W. Park, S.-W. Park, and K.-H. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356 (Pubitemid 44062443)
24. D.-W. Park, and S.-W. Park Stent thrombosis in the era of the drug-eluting stent Korean Circ J 35 2005 791 794
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150